Summary
The AI response contains many specific clinical assertions about vitamin B12 deficiency causes (including associations with Orgovyx/relugolix and other drugs) that are not supported or evaluated against the provided FDA label excerpts, which do not address vitamin B12, nutrition, or those adverse-effect relationships.
Category Scores
Accurate Statements
Unsupported Statements
There is no clear evidence that Orgovyx (relugolix) is a known cause of vitamin B12 deficiency.
The provided FDA label excerpts do not mention vitamin B12 deficiency or relugolix being a cause of it; therefore the claim cannot be supported by the supplied label content.
Vitamin B12 deficiency is not a commonly established adverse effect of Orgovyx’s type of therapy.
No vitamin B12 deficiency adverse-effect information for ORGOVYX is present in the supplied excerpts.
Low vitamin B12 on labs while taking Orgovyx is usually more likely due to other causes rather than Orgovyx itself.
The label excerpts do not include guidance or frequency relating to vitamin B12 lab abnormalities in ORGOVYX-treated patients.
Other causes of low vitamin B12 while taking Orgovyx include dietary insufficiency.
The label excerpts do not discuss vitamin B12 causes or evaluation in ORGOVYX-treated patients.
Other causes of low vitamin B12 while taking Orgovyx include medications such as metformin.
The label excerpts do not discuss vitamin B12 effects of metformin or other therapies in relation to ORGOVYX.
Other causes of low vitamin B12 while taking Orgovyx include acid-suppressing drugs in some patients.
The label excerpts do not discuss vitamin B12 effects of acid-suppressing drugs or any such relationship in ORGOVYX context.
Other causes of low vitamin B12 while taking Orgovyx include malabsorption conditions.
The label excerpts do not address vitamin B12 deficiency etiology or malabsorption evaluation.
Other causes of low vitamin B12 while taking Orgovyx include gastrointestinal issues.
The label excerpts do not address vitamin B12 deficiency etiology or gastrointestinal causes.
Lipitor (atorvastatin) is not recognized as a typical or common cause of vitamin B12 deficiency.
The label excerpts do not mention atorvastatin or vitamin B12 deficiency.
Metformin is associated with reduced vitamin B12 absorption.
The label excerpts do not discuss metformin or vitamin B12 absorption.
Long-term acid suppression (proton pump inhibitors and some H2 blockers) can reduce absorption of protein-bound vitamin B12.
The label excerpts do not discuss protein-bound vitamin B12 absorption or acid suppressants.
Limited dietary intake can cause vitamin B12 deficiency.
The label excerpts do not discuss vitamin B12 deficiency causes.
Limited dietary intake is especially noted for vegan diets without supplementation.
The label excerpts do not discuss diet patterns or vegan diets.
Pernicious anemia can cause vitamin B12 deficiency.
The label excerpts do not discuss pernicious anemia or vitamin B12 deficiency.
Gastric or intestinal disorders that impair absorption can cause vitamin B12 deficiency.
The label excerpts do not discuss gastrointestinal disorders as causes of vitamin B12 deficiency.
Prior GI surgery can cause vitamin B12 deficiency.
The label excerpts do not discuss prior GI surgery or vitamin B12 deficiency.
Vitamin B12 deficiency can cause numbness/tingling in hands/feet.
The label excerpts do not discuss symptoms of vitamin B12 deficiency.
Vitamin B12 deficiency can cause balance problems.
The label excerpts do not discuss vitamin B12 deficiency symptomatology.
Vitamin B12 deficiency can cause fatigue and weakness.
The label excerpts do not discuss vitamin B12 deficiency symptomatology.
Vitamin B12 deficiency can cause glossitis (sore tongue) or mouth sores.
The label excerpts do not discuss vitamin B12 deficiency symptomatology.
Vitamin B12 deficiency can cause memory or mood changes.
The label excerpts do not discuss vitamin B12 deficiency symptomatology.
Delayed treatment of B12 deficiency with neurologic symptoms can lead to longer-lasting nerve effects.
The label excerpts do not discuss treatment timing or outcomes of vitamin B12 deficiency.
Evaluation for the cause of B12 deficiency can include tests such as serum vitamin B12.
The label excerpts do not include vitamin B12 evaluation recommendations.
Evaluation for the cause of B12 deficiency can include methylmalonic acid (MMA) and/or homocysteine testing.
The label excerpts do not include vitamin B12 evaluation recommendations.
Methylmalonic acid (MMA) and/or homocysteine testing are described as more specific for functional B12 deficiency.
The label excerpts do not discuss specificity or functional deficiency testing.
Evaluation for the cause of B12 deficiency can include a CBC (anemia patterns).
The label excerpts do not include vitamin B12 evaluation recommendations.
Evaluation for malabsorption or pernicious anemia may be done if indicated.
The label excerpts do not include vitamin B12 evaluation recommendations.
A clinician can review whether other medications (especially metformin or acid suppressants) are more plausible contributors to low B12.
The label excerpts do not provide such evaluation guidance related to ORGOVYX.
No reliable source information was provided that directly links Orgovyx or Lipitor to vitamin B12 deficiency.
While this is about evidence sources rather than label content, the statement is not something the provided label excerpts can confirm or deny.
If a patient has multiple medications or underlying GI issues, the cause of low B12 can be mixed.
The label excerpts do not address vitamin B12 deficiency causes in ORGOVYX context.
Statins are (less commonly) discussed in relation to liver enzyme changes.
The label excerpts do not mention atorvastatin, statins, or liver enzyme changes in this context.
Statins are more often discussed in relation to muscle side effects.
The label excerpts do not mention statins in this context.
Statins are not typically discussed in relation to B12 malabsorption or deficiency.
The label excerpts do not mention statins and vitamin B12.
Contradictions
Important Omissions
No statements in the AI response align with ORGOVYX label-specific safety monitoring guidance (e.g., PSA monitoring) or contraindications/warnings; this is a material omission only insofar as the response implied medication causality for B12 deficiency without grounding in the ORGOVYX label safety framework.
Importance:
Moderate
The ORGOVYX label provided contains warnings/precautions (e.g., QT/QTc prolongation, hypersensitivity, embryo-fetal toxicity) and notable common adverse reactions (e.g., hot flush, fatigue, constipation/diarrhea). The AI response does not address these label-relevant adverse reaction categories while discussing vitamin B12 deficiency causality.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
High
The AI response asserts multiple clinical causal and evaluation claims about vitamin B12 deficiency and other drugs, but none are supported by the supplied ORGOVYX prescribing information excerpts. This creates risk of misinformation that could misdirect clinical evaluation.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most vitamin B12 deficiency etiologic, symptomatic, diagnostic, and drug-association claims are unsupported by the provided ORGOVYX FDA label excerpts.
Suggested Improvement
Limit statements to what is present in the provided ORGOVYX label (indication, dosing, contraindications, label warnings/precautions, adverse reactions, drug interactions, and label-specific monitoring such as PSA). If vitamin B12 is not addressed in the provided label excerpts, avoid claiming relationships or typicality and instead state that the supplied ORGOVYX label excerpts do not mention vitamin B12.